Skip to content

Effect of red wine ingestion on resveratrol plasma and urine levels and on hemodynamic parameters in humans

Effect of red wine ingestion on resveratrol plasma and urine levels and on hemodynamic parameters in humans

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00015062
Enrollment
30
Registered
2018-07-09
Start date
2018-07-16
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Group 1: Included test persons are subjected to the following examinations: - Collection of a plasma sample (equivalent to approx. 15 ml whole blood) from a peripheral vein - Delivery of a urine samp

Sponsors

Universitätsklinikum Bonn
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - age of >18 years - Ability to give legal consent - male sex (inability to become pregnant) - informed written consent

Exclusion criteria

Exclusion criteria: Answer one of the following questions with "Yes": - Do you regularly take medication? - Do you have an acute or chronic disease? - Do you have or are you suffering from an addiction disorder of any kind (alcohol, medication, drugs)? - Are you feeling sick? - Any complaints after a previous blood withdrawal (fainting, infections, etc.)? - Have you ever had any problems with red wine (consumed in the usual quantities)?

Design outcomes

Primary

MeasureTime frame
Resveratrol plasma concentration 60 min after ingestion of the test fluid compared to baseline

Secondary

MeasureTime frame
- Resveratrol urine concentration 120 min after ingestion of test fluid compared to baseline - Hemodynamics (HF, RR) 60 min after ingestion of test fluid compared to baseline - Brachial artery diameter sonographically 60 min after ingestion of the test fluid compared to baseline - microvascular reactivity 60 min after ingestion of test fluid compared to baseline

Countries

Germany

Contacts

Public ContactTobias Hilbert

Universitätsklinikum Bonn

thilbert@uni-bonn.de0228 - 287 - 14114

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026